tm logo

Monitor this mark

View On USPTO

STRENSIQ
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 28 Apr 2021

Last Applicant/ Owned by

Alexion Pharmaceuticals, Inc.

121 Seaport Boulevard

Boston

MA

02210

Serial Number

86105490 filed on 30th Oct 2013

Registration Number

4874927 registered on 22nd Dec 2015

in the Principal Register

Correspondent Address

Tara Rahemba

Tara Rahemba Alexion Pharmaceuticals, Inc.

Boston, MA 02210

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

STRENSIQ

Pharmaceutical preparations for the treatment of disorders of the metabolic system

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of disorders of the metabolic system

First Use Date in General

04th Nov 2015

First Use Date in Commerce

04th Nov 2015

Mark Details

Serial Number

No 86105490

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
22nd Dec 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11th Apr 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
11th Apr 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11th Apr 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28th Apr 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
28th Apr 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
28th Apr 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07th Jan 2021TEAS SECTION 8 & 15 RECEIVED
22nd Dec 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09th Nov 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED